Calliditas Therapeutics
CALT
$20.00
Share price
-0.25%
Change (1 day)
-17.70%
Change (1 year)
Categories
P/S ratio for Calliditas Therapeutics (CALT)
P/S ratio as of May 2024 (TTM): 3.70
According to Calliditas Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.69827. At the end of 2023 the company had a P/S ratio of 4.40.
P/S ratio history for Calliditas Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.40 | -25.89% |
| 2022 | 5.93 | -76.2% |
| 2021 | 24.9 | -99.71% |
| 2020 | > 1000 |